Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR3E | A5X5Y0 | 2/20 | 0.52 |
| ▸ | HTR3B | O95264 | 2/20 | 0.52 |
| ▸ | HTR3A | P46098 | 2/20 | 0.52 |
| ▸ | HTR3D | Q70Z44 | 2/20 | 0.52 |
| ▸ | HTR3C | Q8WXA8 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 5/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.50 |
| ▸ | NPC1 | O15118 | 4/20 | 0.50 |
| ▸ | RAB9A | P51151 | 4/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 5/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6435930 | 1.00 | HTR3E (0.52) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL1354442 | 0.93 | HTR3E (0.58) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL6542062 | 0.85 | HTR3E (0.50) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL6542073 | 0.85 | HTR3E (0.50) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL6541318 | 0.85 | HTR3E (0.50) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL6422598 | 0.81 | CYP2A6 (0.54) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL10349716 | 0.81 | MEN1 (0.73) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL2291265 | 0.81 | MEN1 (0.73) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL10017620 | 0.77 | MEN1 (0.75) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL3283287 | 0.77 | MEN1 (0.75) | HTR3EHTR3BHTR3AHTR3DHTR3C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10069075-B2 | Charge-transporting varnish | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2018-09-04 | — | — | US | claimed |
| US-20160005975-A1 | CHARGE-TRANSPORTING VARNISH | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-01-07 | — | — | US | claimed |
| EP-2963699-A1 | CHARGE-TRANSPORTING VARNISH | Nissan Chemical Industries, Ltd. (JP) | 2016-01-06 | — | — | EP | claimed |
| US-7534853-B2 | Rhodium and iridium complexes | MERCK PATENT GMBH (DE) | 2009-05-19 | — | — | US | claimed |
| US-20080220286-A1 | Electroluminescent compound; high color purity, high fluorescence yield, and high electric luminance yield; easy to synthesize and can easily form films | TSINGHUA UNIVERSITY (CN) | 2008-09-11 | — | — | US | claimed |
| CN-100357388-C | Organic electroluminescent compositions | 3M INNOVATIVE PROPERTIES CO (US) | 2007-12-26 | — | — | CN | claimed |
| US-7094897-B2 | Rhodium and iridium complexes | COVION ORGANIC SEMICONDUCTORS GMBH (DE) | 2006-08-22 | — | — | US | claimed |
| US-20060065890-A1 | Rhodium and iridium complexes | COVION ORGANIC SEMICONDUCTORS GMBH (DE) | 2006-03-30 | — | — | US | claimed |
| CN-1681903-A | organic electroluminescent composition | 3M INNOVATIVE PROPERTIES CO (US) | 2005-10-12 | — | — | CN | claimed |
| EP-1554360-A2 | ORGANIC ELECTROLUMINESCENT COMPOSITIONS | 3M Innovative Properties Company (US) | 2005-07-20 | — | — | EP | claimed |
| EP-1379534-B1 | RHODIUM AND IRIDIUM COMPLEXES | COVION ORGANIC SEMICONDUCTORS (DE) | 2004-12-15 | — | — | EP | claimed |
| WO-2004099338-A2 | ORGANIC ELECTROLUMINESCENT COMPOSITIONS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2004-11-18 | — | — | WO | claimed |
| US-20040133004-A1 | Rhodium and iridium complexes | MERCK PATENT GMBH (DE) | 2004-07-08 | — | — | US | claimed |
| US-20040062947-A1 | Organic electroluminescent compositions | 3M INNOVATIVE PROPERTIES COMPANY | 2004-04-01 | — | — | US | claimed |
| US-6346621-B1 | INDOLE OR QUINOLINE COMPOUNDS SUBSTITUTED WITH AMINO COMPOUNDS ON NITROGEN | TOSOH CORPORATION (JP) | 2002-02-12 | — | — | US | claimed |
| EP-4365180-A1 | RARE EARTH COMPLEX | Tosoh Corporation (JP) | 2024-05-08 | — | — | EP | disclosed |
| CN-117616032-A | Rare earth complex | 东曹株式会社 | 2024-02-27 | — | — | CN | disclosed |
| US-5624935-A | ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS | SANKYO COMPANY, LIMITED | 1997-04-29 | — | — | US | disclosed |
| CN-1118781-A | Heterocyclic compound with activity against diabetes and preparation and application of same | MITSUTAKA CO LTD (JP) | 1996-03-20 | — | — | CN | disclosed |
| EP-0676398-A2 | Heterocyclic compounds having anti-diabetic activity, their preparation and their use | SANKYO COMPANY LIMITED (JP) | 1995-10-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060065890-A1 | Rhodium and iridium complexes | RPIA, INPP5B, SIRT5 | HTR3E 4257/4885HTR3B 4649/4885HTR3A 4643/4885 |
| US-20080220286-A1 | Electroluminescent compound; high color purity, high fluorescence yield, and high electric luminance yield; easy to synthesize and can easily form films | EED, DDT, RABL6 | HTR3E 1478/4885HTR3B 2809/4885HTR3A 3048/4885 |
| US-20040133004-A1 | Rhodium and iridium complexes | RPIA, SIRT5, INPP5B | HTR3E 4196/4885HTR3B 4607/4885HTR3A 4634/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.